World Health Organisation
How the WHO hepatitis strategy measures up in the field
With hepatitis cases on the rise, Dr Anthony Martinez, member of the International Hepatitis Education Program (IHEP), shares his perspective on the World Health Organization’s new strategy for hepatitis elimination...
World Hepatitis Day highlights need to reach 2030 elimination target
According to the World Hepatitis Alliance, someone dies from a viral hepatitis-related illness every 30 seconds
Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic
Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...
Gilead set to acquire hepatitis specialist MYR for €1.15bn
Acquisition will see Gilead pick up HDV treatment Hepcludex
Just 20% of people living with hep C are aware of their status
WHO's hepatitis report reveals global impact of the disease
Merck & Co posts positive hepatitis C data
Elbasvir/grazoprevir achieves high cure rates for patients who inject drugs
NICE backs three hepatitis C meds, turns down Duchenne drug
Benefits of short treatments with high cure rates reinforces drugs value
Gilead reports positive data on ‘universal’ hepatitis C regimen
Sets sights on regulatory approval for combination therapy
First-ever World Hepatitis Summit calls for national programmes
Follows rise in hepatitis deaths for fifth consecutive year
Merck files all-oral hepatitis C therapy in US
Seeking approval for grazoprevir and elbasvir, which already has FDA breakthrough status